Seminars

  • All

  • Month

  • Year

Nov 26, 2026

Decoding disease through spatial biology: from viral signalling to glycan-mediated immune regulation in lymphoma

Speaker: Dr. Stephanie Yui

Postdoctoral research fellow, Beth Israel Deaconess Medical Centre, Harvard Medical School

 

School of Biomedical Sciences cordially invites you to join the following seminar:

Date: 26 November 2026 (Thursday)
Time: 5:00 pm – 6:00 pm
Venue: Faculty Boardroom, 1/F, Daniel & Mayce Yu Administration Wing, Faculty of Medicine Building,21 Sassoon Road
Host: Professor Dong-Yan Jin

Biography

Dr. Stephanie Yiu is a postdoctoral research fellow at Beth Israel Deaconess Medical Centre/Harvard Medical School working at the intersection of spatial biology, glycoimmunology, and tumour microenvironment research. Her work centres on glycosylation, one of the most pervasive yet underexplored features of cancer. She investigates how the glycans decorating tumour and immune cell surfaces reorganize the microenvironment and drive immune evasion, a molecular dimension that remains largely invisible to conventional proteomic and transcriptomic approaches. To interrogate it, she has co-developed GlycoScope-IN-DEPTH, a suite of spatial profiling technologies that resolve proteins, transcripts, and glycans concurrently at single-cell resolution within intact tissue, coupled with organ-on-chip disease models that establish causality for the interactions she identifies. Applying this framework across B cell lymphomas, she has delineated how immunosuppressive niches are spatially assembled and nominated glycan-lectin interactions as candidate immunotherapeutic targets, with recent work in Cancer Discovery and Nature Biotechnology. During her doctoral work at Harvard, she mapped the EBV-B cell protein interaction network and characterized mechanisms of viral innate immune evasion, which now informs her spatial dissection of virus-associated malignancies.

Abstract

Understanding how cells communicate within their native tissue environment is fundamental to deciphering disease mechanisms. Recent advances in spatial biology have transformed our ability to study tissues in situ, yet most existing approaches capture only a single molecular modality or rely on measurements from adjacent tissue sections, limiting our understanding of complex cellular interactions. In this talk, I will present our efforts to develop integrated spatial multiomic technologies that enable simultaneous profiling of proteins, transcripts, and glycans from the same tissue section at single-cell resolution. We first dissected the tumour microenvironment of Epstein-Barr virus (EBV)-positive and EBV-negative diffuse large B-cell lymphoma using same-slide spatial proteomics and transcriptomics (IN-DEPTH), revealing how viral LMP1 signalling spatially coordinates macrophage polarization and T cell dysfunction through a candidate cytokine axis with therapeutic potential. Extending this framework to glycan biology (GlycoScope-IN-DEPTH), we added single-cell glycan detection to the same tissue section. Applied to follicular lymphoma, this approach uncovered a disease-specific redistribution of a glycan epitope on neoplastic B cells that defines spatially distinct immune niches, linking glycan remodelling to dysregulated T cell and macrophage states. Together, these studies demonstrate how spatial multiomic can move beyond descriptive tissue mapping to reveal mechanistic insights into disease biology and identify new opportunities for therapeutic intervention.

 

All are welcome.

New Releases